Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation

References

• Checherita IA, Turcu F, Dragomirescu RF, Ciocalteu A. Chroniccomplications in hemodialysis: correlations with primary renal disease. Rom J Morphol Embryol 2010;51: 21–26.
   PubMedGoogle Scholar
• Perez-Garcia R, Palomares-Sancho I, Merello-Godino JI, Aljama-Garcia P, Bustamante-Bustamante J, Luno J, et al. Grupo ORD (Optimizando Resultados de Dialisis). Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: results from years 2009–2010. Nefrologia 2012; 32:743–753.
   PubMedGoogle Scholar
• Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A.Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients. Hemodial Int 2010;14:226–232.
   PubMedGoogle Scholar
• Ruskovska T. hsCRP and all-cause mortality in hemodialyzed patients. Rev Global Med Healthcare Res 2011;2:72–78.
   Google Scholar
• Racki S, Zaputovic L, Mavric Z, Vujicic B, Dvornik S. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Ren Fail 2006;28:427–433.
   PubMed Web of Science ®Google Scholar
• Ishii T, Ohtake T, Okamoto K, Mochida Y, Ishioka K, Oka M, et al. Serum biological antioxidant potential predicts the prognosis of hemodialysis patients. Nephron Clin Pract 2011; 117:c230–236.
   PubMedGoogle Scholar
• Del Vecchio L, Locatelli F, Carini M. What we know about oxidative stress in patients withchronic kidney disease on dialysis–clinical effects, potential treatment, and prevention. Semin Dial 2011;24:56–64.
   PubMed Web of Science ®Google Scholar
• Mekki K, Taleb W, Bouzidi N, Kaddous A, Bouchenak M. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study. Lipids Health Dis 2010;9:93.
   PubMedGoogle Scholar
• Himmelfarb J. Oxidative stress in hemodialysis. Contrib Nephrol 2008;161:132–137.
   PubMed Web of Science ®Google Scholar
• Celik G, Yontem M, Bilge M, Cilo M, Unaldi M. The relationship between the antioxidant system and anaemia in haemodialysis patients. J Int Med Res 2011;39:1954–1960.
   PubMedGoogle Scholar
• Tonon J, Guarnier FA, Cecchini AL, Cecchini R. Anemia associated with extraerythrocytic oxidative stress damage mediated by neutrophil superoxide anion production in chronic renal failure patients undergoing hemodialysis. Pathophysiology 2012;19:261–268.
   PubMedGoogle Scholar
• Handelman GJ, Levin NW. Red cell survival: relevance and mechanism involved. J Ren Nutr 2010;20:S84–88.
   PubMed Web of Science ®Google Scholar
• Siems W, Carluccio F, Radenkovic S, Grune T, Hampl H. Oxidative stress in renalanemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res 2005; 28:295–301.
   PubMed Web of Science ®Google Scholar
• Hasuike Y, Nagai T, Yorifuji S, Tanaka S, Matsumoto A, Yahiro M, et al. The mitochondrial protein frataxin is downregulated in hemodialysis patients. Clin Exp Nephrol 2013; 17:424–430.
   PubMedGoogle Scholar
• Ersson C, Odar-Cederlof I, Fehrman-Ekholm I, Moller L. The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay. Hemodial Int 2013;17:366–373.
   PubMedGoogle Scholar
• Sanaka T, Koremoto M. Selection guidelines for high- performance membrane. Contrib Nephrol 2011;173:30–35.
   PubMedGoogle Scholar
• Mandolfo S, Corradi B, Bucci R, Farina M, Pilolli F, Galli F. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: a pilot study. Int Urol Nephrol 2012;44:1493–1500.
   PubMedGoogle Scholar
• Cruz DN, De Cal M, Garzotto F, Brendolan A, Nalesso D, Corradi V, Ronco C. Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. Int J Artif Organs 2008;31:545–552.
   PubMedGoogle Scholar
• Rusu A, Rusu F, Zalutchi D, Muresan A, Gherman Caprioara M, Kacso I. The influence of vitamin E supplementation on erythropoietin responsiveness in chronichemodialysis patients with low levels of erythrocyte superoxide dismutase. Int Urol Nephrol 2013;45:495–501.
   PubMed Web of Science ®Google Scholar
• Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis 2011;58:591–598.
   PubMed Web of Science ®Google Scholar
• Hirano H, Tone Y, Otani H, Oya M, Kimura K, Saika Y, et al. [Levels of serum ascorbate and its metabolites in hemodialysis patients]. Nihon Jinzo Gakkai Shi 2004;46:426–433.
   PubMedGoogle Scholar
• Sirover WD, Siddiqui AA, Benz RL. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study. Ren Fail 2008;30:884–889.
   PubMed Web of Science ®Google Scholar
• Biesalski HK.Parenteral ascorbic acid in haemodialysis patients. Curr Opin Clin Nutr Metab Care 2008;11:741–746.
   PubMedGoogle Scholar
• Chao JC, Yuan MD, Chen PY, Chien SW. VitaminC and E supplements improve the impaired antioxidant status and decrease plasma lipid peroxides in hemodialysispatients small star, filled. J Nutr Biochem 2002;13:653–663.
   PubMedGoogle Scholar
• Einerson B, Nathorn C, Kitiyakara C, Sirada M, Thamlikitkul V.The efficacy of ascorbic acid in suboptimal responsive anemic hemodialysis patients receiving erythropoietin: a meta-analysis. J Med Assoc Thai 2011;94:S134–146.
   Google Scholar
• Deved V, Poyah P, James MT, Tonelli M, Manns BJ, Walsh M, Hemmelgarn BR. Alberta Kidney Disease Network. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54:1089–1097.
   PubMed Web of Science ®Google Scholar
• Canavese C, Petrarulo M, Massarenti P, Berutti S, Fenoglio R, Pauletto D, et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 2005;45:540–549.
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Borrey D, Mahieu E, Claeys I, Stevens L, Vanhaeverbeke A, et al. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients. Nephron Clin Pract 2008;108:c28–34.
   Google Scholar
• Alvarez-Llamas G, Zubiri I, Maroto AS, de la Cuesta F, Posada-Ayala M, Martin-Lorenzo M, et al. A role for the membrane proteome in human chronic kidney disease erythrocytes. Transl Res 2012;160:374–383.
   PubMed Web of Science ®Google Scholar
• Jha R, Rizvi SI. Carbonylformation in erythrocyte membrane proteins during aging in humans. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011;155:39–42.
   PubMed Web of Science ®Google Scholar
• Margetis PI, Antonelou MH, Petropoulos IK, Margaritis LH, Papassideri IS.Increasedproteincarbonylation of redbloodcellmembrane in diabeticretinopathy. Exp Mol Pathol 2009; 87:76–82.
   PubMedGoogle Scholar
• Marchesi VT, Palade GE. The localization of Mg-Na-K- activatedadenosine triphosphatase on red cell ghost membranes. J Cell Biol 1967;35:385–404.
   PubMed Web of Science ®Google Scholar
• Carty JL, Bevan R, Waller H, Mistry N, Cooke M, Lunec J, Griffiths HR. The effects of vitamin Csupplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Commun 2000;273:729–735.
   PubMed Web of Science ®Google Scholar
• Turner JE, Bennett SJ, Campbell JP, Bosch JA, Aldred S, Griffiths HR. The antioxidant enzyme peroxiredoxin-2 is depleted in lymphocytes seven days after ultra-endurance exercise. Free Radic Res 2013;47:821–828.
   PubMed Web of Science ®Google Scholar
• Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 1996;239:70–76.
   PubMed Web of Science ®Google Scholar
• Jansen EH, Ruskovska T. Comparative analysis of serum (anti)oxidative status parаmeters in healthy persons. Int J Mol Sci 2013;14:6106–6115.
   PubMed Web of Science ®Google Scholar
• Petz B. Dodatak. In: Osnovnestatistickemetodezanematematicare. 2nd ed. ManualiaUniversitatisStudiorumZagrabiensis, SNL, Zagreb, Croatia; 1985.p 344.
   Google Scholar
• Hall TG, Bennett V. Regulatory domains of erythrocyte ankyrin.J BiolChem 1987;262:10537–10545.
   Google Scholar
• Ruskovska T, Jansen EHJM, Antarorov R. Evaluation of assays for measurement of serum (anti)oxidants in hemodialysis patients. BioMed Res Int 2014; doi:10.1155/2014/843157.
   PubMedGoogle Scholar
• Ruskovska T, Dimovska J, Georgieva B, Nikolovski A. Influence of lovastatin and combined antioxidant therapy on oxidative status parameters. Society for Free Radical Research International, Proceedings of the XIII Biennial Congress, Davos, Switzerland. Medimond International Proceedings 2006 August 15–19;299–303.
   Google Scholar
• Huang H, Zhao P, Arimatsu K, Tabeta K, Yamazaki K, Krieg L, et al. A deep intronicmutation in the ankyrin-1 gene causes diminished protein expression resulting in hemolytic anemia in mice. G3 (Bethesda) 2013;3:1687–1695.
   PubMedGoogle Scholar
• Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004;19:121–132.
   PubMed Web of Science ®Google Scholar
• Dutka P. Erythropoiesis-stimulating agents for the management of anemia of chronic kidney disease: past advancements and current innovations. Nephrol Nurs J 2012;39:447–457.
   PubMedGoogle Scholar
• Thakuria M, Ofsthun NJ, Mullon C, Diaz-Buxo JA. Anemia management in patients receiving chronic hemodialysis. Semin Dial 2011;24:597–602.
   PubMedGoogle Scholar
• Locatelli F, Becker H. Update on anemiamanagement in nephrology, includingcurrent guidelines on the use of erythropoiesis-stimulating agents and implications of the introduction of “biosimilars”. Oncologist 2009;14:S16–21.
   PubMedGoogle Scholar
• Singh AK. What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? Curr Opin Nephrol Hypertens 2010;19:420–424.
   PubMedGoogle Scholar
• Khoueiry G, Abdallah M, Saiful F, Abi Rafeh N, Raza M, Bhat T, et al. High-density lipoprotein in uremic patients: metabolism, impairment, and therapy. Int Urol Nephrol 2014; 46:27–39.
   PubMedGoogle Scholar
• Goncalves MS, Fabris BA, Brinholi FF, Bortolasci CC, Watanabe MA, Oliveira KB, et al. Increased oxidative stress in foam cells obtained from hemodialysis patients. Hemodial Int 2013;17:266–274.
   PubMedGoogle Scholar
• Samouilidou EC, Karpouza AP, Kostopoulos V, Bakirtzi T, Pantelias K, Petras D, et al. Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis. Ren Fail 2012;34:160–164.
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;3:CD007176.
   PubMedGoogle Scholar
• Dotan Y, Lichtenberg D, Pinchuk I. No evidence supports vitamin E indiscriminate supplementation. Biofactors 2009, 35:469–473.
   PubMed Web of Science ®Google Scholar
• Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev 2012;10:CD008176.
   PubMedGoogle Scholar
• Coombes JS, Fassett RG. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int 2012;81: 233–246.
   PubMed Web of Science ®Google Scholar
• Kamgar M, Zaldivar F, Vaziri ND, Pahl MV. Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. J Natl Med Assoc 2009;101:336–344.
   PubMed Web of Science ®Google Scholar
• Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E.Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541–1551.
   PubMed Web of Science ®Google Scholar